Supreme Court to hear PIL on Ranbaxy next week

The Supreme Court on Friday would be hearing next week a Public Interest Litigation seeking cancellation of licence granted to Ranbaxy and for initiating probe against it for allegedly manufacturing and selling adulterated medicines.

"I have directed that the matter be listed (for hearing) next week," a bench headed by Justice Gyan Sudha Misra said when lawyer M L Sharma mentioned the case this morning seeking early hearing of the PIL against the pharma major.